164 related articles for article (PubMed ID: 7333345)
1. Disposition and clinical pharmacokinetics of theophylline after administration of a new sustained release tablet.
Jonkman JH; Berg WC; de Vries K; de Zeeuw RA; Schoenmaker R; Grimberg N
Eur J Clin Pharmacol; 1981; 21(1):39-44. PubMed ID: 7333345
[TBL] [Abstract][Full Text] [Related]
2. Disposition and clinical pharmacokinetics of microcrystalline theophylline.
Jonkman JH; Berg WC; Schoenmaker R; de Zeeuw RA; Greving JE; Orie NG
Eur J Clin Pharmacol; 1980 May; 17(5):379-84. PubMed ID: 7418716
[TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetics and pharmacodynamics of a short- and long-acting theophylline medication (theolair and Theolair retard) in normals and asthmatics. Part I: pharmacokinetics.
Utama I; Kreukniet J; Meering PG; Maes RA
Int J Clin Pharmacol Ther Toxicol; 1983 Jun; 21(6):287-91. PubMed ID: 6885202
[TBL] [Abstract][Full Text] [Related]
4. Bioavailability of theophylline from a sustained-release aminophylline formulation (Euphyllin retard tablets)--plasma levels after single and multiple oral doses.
Schuppan D; Molz KH; Staib AH; Rietbrock N
Int J Clin Pharmacol Ther Toxicol; 1981 May; 19(5):223-7. PubMed ID: 7251238
[TBL] [Abstract][Full Text] [Related]
5. Chronopharmacokinetics of theophylline after sustained release and intravenous administration to adults.
Jonkman JH; van der Boon WJ; Balant LP; Schoenmaker R; Holtkamp A
Eur J Clin Pharmacol; 1984; 26(2):215-22. PubMed ID: 6723760
[TBL] [Abstract][Full Text] [Related]
6. Greatly enhanced bioavailability of theophylline on postprandial administration of a sustained release tablet.
Lagas M; Jonkman JH
Eur J Clin Pharmacol; 1983; 24(6):761-7. PubMed ID: 6884413
[TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetics and pharmacodynamics of three sustained-release theophylline preparations (350 mg Theograd, 350 mg Theolair Retard and 300 mg Theodur) in steady state in healthy volunteers and asthmatics--Part I: Theophylline plasma levels.
van der Vet AP; Drost RH; Kreukniet J; Maes RA
Int J Clin Pharmacol Ther Toxicol; 1984 Aug; 22(8):423-9. PubMed ID: 6490224
[TBL] [Abstract][Full Text] [Related]
8. The absolute bioavailability of a new pediatric sustained release theophylline tablet, when given as whole or divided tablets.
Jonkman JH; van der Boon WJ; Schoenmaker R; Holtkamp A; Thürkow-Luikens AJ
Int J Clin Pharmacol Ther Toxicol; 1984 Sep; 22(9):506-10. PubMed ID: 6500770
[TBL] [Abstract][Full Text] [Related]
9. Bioavailability and pharmacokinetics of theophylline in plain uncoated and sustained-release dosage forms in relation to smoking habit. I. Single dose study.
Horai Y; Ishizaki T; Sasaki T; Chiba K; Suganuma T; Echizen H; Ohnishi A
Eur J Clin Pharmacol; 1983; 24(1):79-87. PubMed ID: 6832206
[TBL] [Abstract][Full Text] [Related]
10. [Bioavailability of 3 theophylline delayed-release preparations. Comparison of theophylline concentrations in the serum and saliva in the steady state].
Bochsler HP; Meyer UA
Schweiz Med Wochenschr; 1982 Nov; 112(47):1702-10. PubMed ID: 7178872
[TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetic disposition of an immediate-release aminophylline and a sustained-release theophylline formulation in the horse.
Goetz TE; Munsiff IJ; McKiernan BC
J Vet Pharmacol Ther; 1989 Dec; 12(4):369-77. PubMed ID: 2614856
[TBL] [Abstract][Full Text] [Related]
12. Conversion from intravenous to oral dosing using sustained-release theophylline tablets.
Stein GE; Haughey DB; Ross RJ; Vakoutis J
Drug Intell Clin Pharm; 1982 Oct; 16(10):772-4. PubMed ID: 7140514
[TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetic properties of a new sustained-release theophylline preparation.
Dahlqvist R; Billing B
Int J Clin Pharmacol Ther Toxicol; 1983 Feb; 21(2):69-72. PubMed ID: 6840927
[TBL] [Abstract][Full Text] [Related]
14. Absorption of sustained-release theophylline tablets.
Fagerström PO; Heintz L
Int J Clin Pharmacol Ther Toxicol; 1983 Jul; 21(7):359-62. PubMed ID: 6885207
[TBL] [Abstract][Full Text] [Related]
15. Food and a sustained release theophylline tablet on chronic dosing: bioavailability, peak-trough and trough-trough differences.
Lagas M; Jonkman JH
Pharm Weekbl Sci; 1985 Feb; 7(1):10-4. PubMed ID: 3982951
[TBL] [Abstract][Full Text] [Related]
16. Comparison of steady state serum theophylline concentrations in healthy volunteers after dosing with Euphyllin retard and PulmiDur.
Karlsson S; Lührmann B; Bahner ML; Schulz HU
Int J Clin Pharmacol Ther Toxicol; 1987 Jun; 25(6):342-6. PubMed ID: 3623739
[TBL] [Abstract][Full Text] [Related]
17. Circadian changes in the absorption and elimination of theophylline in patients with bronchial obstruction.
Uematsu T; Follath F; Vozeh S
Eur J Clin Pharmacol; 1986; 30(3):309-12. PubMed ID: 3732366
[TBL] [Abstract][Full Text] [Related]
18. Bioavailability and pharmacokinetics in man of orally administered theophylline.
Nielsen-Kudsk F; Magnussen I; Jensen TS; Naeser K
Acta Pharmacol Toxicol (Copenh); 1980 Mar; 46(3):205-12. PubMed ID: 7361576
[TBL] [Abstract][Full Text] [Related]
19. Bioavailability of Theodel, a new theophylline tablet, in humans.
Rovei V; Strolin Benedetti M; Donath A; Grenot C; Chanoine F
Int J Clin Pharmacol Ther Toxicol; 1983 Aug; 21(8):425-30. PubMed ID: 6629546
[TBL] [Abstract][Full Text] [Related]
20. Food does not effect in bioavailability of theophylline from Theolin Retard.
Sips AP; Edelbroek PM; Kulstad S; de Wolff FA; Dijkman JH
Eur J Clin Pharmacol; 1984; 26(3):405-7. PubMed ID: 6734703
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
